New sedative tested to keep ICU patients comfortable
NCT ID NCT06222294
Summary
This study tested whether a medication called remimazolam could safely and effectively keep ICU patients sedated at the right level while they were on breathing machines. Researchers compared it to another active sedative in 214 adult ICU patients who needed at least 6 hours of sedation. The main goal was to see how well it maintained the target sedation level without needing extra rescue medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION IN THE ICU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.